More Company News

MaxCyte

SPL with Curamys
05 Dec 2022Read More

MaxCyte

Q322 results
09 Nov 2022Read More

MaxCyte

SPL with Vertex Pharmaceuticals
28 Sep 2022Read More

MaxCyte

New Maryland headquarters
21 Sep 2022Read More

MaxCyte

Q222 results
10 Aug 2022Read More

MaxCyte

Strategic platform license
12 Jul 2022Read More

MaxCyte

Q122 results
09 May 2022Read More

MaxCyte

CFO departure and preliminary Q122 revenue
13 Apr 2022Read More

MaxCyte

Q421 and FY21 financial results
22 Mar 2022Read More

MaxCyte

Cenk Sumen named Chief Scientific Officer
10 Mar 2022Read More

1 2 3 4 … 9
Return to MaxCyte
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).